GBR-12935 HCl - CAS# 67469-81-2 Catalog No.:M7140-2 Tyrosine kinase inhibitor SU11274 increased

Tyrosine kinase inhibitor SU11274 increased tumorigenicity and enriched for melanoma-initiating cells by bioenergetic modulation

CHIR-090 at low nM levels inhibits LpxC orthologues from diverse Gram-negative pathogens

and 30 μM

Netarsudil/latanoprost fixed-dose combination for the treatment of open-angle glaucoma or ocular hypertension

GBR-12935 HCl - CAS# 67469-81-2 Catalog No.:M7140-2 Tyrosine kinase inhibitor SU11274 increasedGBR 12935 HCl, CAS No. 67469 81 2, is a piperazine derivative which is a potent and selective dopamine reuptake inhibitor. It was originally developed in its 3H radiolabelled form for the purpose of mapping the distribution of dopaminergic neurons in the brain by selective labelling of dopamine transporter proteins. This has led to potential clinical uses in the diagnosis of Parkinson's disease, although selective radioligands such as Ioflupane (I)